TY - JOUR
T1 - A case of antibiotic-associated encephalopathy with very high blood concentrations of ceftriaxone in a low-body-weight patient on hemodialysis
AU - Uchida, Hiroyuki
AU - Sakaguchi, Takashi
AU - Hongo, Igen
AU - Shinoda, Kozue
AU - Tashiro, Sho
AU - Matsumoto, Kazuaki
AU - Samura, Masaru
AU - Kato, Tomoyuki
AU - Sekiguchi, Mana
AU - Nakajima, Miharu
AU - Mitsuda, Masaki
AU - Kawai, Yoshitomo
N1 - Publisher Copyright:
© 2021 Japan Society of Chemotherapy. All rights reserved.
PY - 2021/11
Y1 - 2021/11
N2 - We encountered a patient under maintenance hemodialysis with suspected antibiotic-associated encephalopathy (AAE) caused by ceftriaxone (CTRX), a third-generation cephalosporin. The patient was an 83-year-old woman, 140 cm tall, with a body weight of 37 kg. She was treated with 2 g CTRX daily for bacteremia starting on day 3 of admission. Transient alteration of consciousness was observed on day 8 of admission, and on day 14 of admission, the patient became unconscious, with a Glasgow Coma Scale of El VlMl. We considered the possibility of AAE caused by CTRX, as well as the possibility of infection, vitamin deficiency, and epileptic seizures, _and discontinued CTRX administration. On day 16 of admission, her electroencephalogram showed slow waves and triphasic waves. Then, on day 23 of admission, the slow waves completely disappeared. Later, it was found that the trough concentration of CTRX on day 8 of admission was markedly elevated to 1,077.6 μg/mL. The consciousness level improved with decrease in the blood CTRX concentrations, but only 6 days after discontinuation of CTRX. We considered that the markedly elevated blood CTRX concentrations were due to the severe renal dysfunction and reduced excretion of the drug on account of inefficient dialysis conditions, and the relatively high dose of the drug administered to a patient with a low-body-weight We wish to emphasize the need to pay attention to the dosage of CTRX in patients with these characteristics and the need to measure the blood CTRX concentrations without delay in patients with suspected AAE.
AB - We encountered a patient under maintenance hemodialysis with suspected antibiotic-associated encephalopathy (AAE) caused by ceftriaxone (CTRX), a third-generation cephalosporin. The patient was an 83-year-old woman, 140 cm tall, with a body weight of 37 kg. She was treated with 2 g CTRX daily for bacteremia starting on day 3 of admission. Transient alteration of consciousness was observed on day 8 of admission, and on day 14 of admission, the patient became unconscious, with a Glasgow Coma Scale of El VlMl. We considered the possibility of AAE caused by CTRX, as well as the possibility of infection, vitamin deficiency, and epileptic seizures, _and discontinued CTRX administration. On day 16 of admission, her electroencephalogram showed slow waves and triphasic waves. Then, on day 23 of admission, the slow waves completely disappeared. Later, it was found that the trough concentration of CTRX on day 8 of admission was markedly elevated to 1,077.6 μg/mL. The consciousness level improved with decrease in the blood CTRX concentrations, but only 6 days after discontinuation of CTRX. We considered that the markedly elevated blood CTRX concentrations were due to the severe renal dysfunction and reduced excretion of the drug on account of inefficient dialysis conditions, and the relatively high dose of the drug administered to a patient with a low-body-weight We wish to emphasize the need to pay attention to the dosage of CTRX in patients with these characteristics and the need to measure the blood CTRX concentrations without delay in patients with suspected AAE.
KW - antibiotic-associated encephalopathy
KW - ceftriaxone
KW - hemodialysis
KW - low-body-weight
UR - http://www.scopus.com/inward/record.url?scp=85129260093&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129260093&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85129260093
SN - 1340-7007
VL - 69
SP - 433
EP - 439
JO - Japanese Journal of Chemotherapy
JF - Japanese Journal of Chemotherapy
IS - 6
ER -